These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34027386)

  • 1. Use of simulated vaginal and menstrual fluids to model
    McCoy CF; Spence P; Dallal Bashi YH; Murphy DJ; Boyd P; Dangi B; Derrick T; Devlin B; Kleinbeck K; Malcolm RK
    Int J Pharm X; 2021 Dec; 3():100081. PubMed ID: 34027386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel.
    Dallal Bashi YH; Murphy DJ; McCoy CF; Boyd P; Brown L; Kihara M; Martin F; McMullen N; Kleinbeck K; Dangi B; Spence P; Hansraj B; Devlin B; Malcolm RK
    Int J Pharm X; 2021 Dec; 3():100091. PubMed ID: 34977558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
    Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK
    J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Murphy DJ; Dallal Bashi YH; McCoy CF; Boyd P; Brown L; Martin F; McMullen N; Kleinbeck K; Dangi B; Spence P; Hansraj B; Devlin B; Malcolm RK
    Int J Pharm X; 2022 Dec; 4():100112. PubMed ID: 35128382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
    Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK
    Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers.
    Dallal Bashi YH; McCoy CF; Murphy DJ; Boyd P; Spence P; Kleinbeck K; Devlin B; Malcolm RK
    Int J Pharm; 2019 Oct; 569():118574. PubMed ID: 31352053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
    Nel A; Bekker LG; Bukusi E; Hellstrӧm E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C
    PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring.
    McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
    J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug stability and product performance characteristics of a dapivirine-releasing vaginal ring under simulated real-world conditions.
    Murphy DJ; McCoy CF; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
    Int J Pharm; 2019 Jun; 565():351-357. PubMed ID: 31085254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP; Andrade AT; Pizarro E
    Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device.
    Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK
    J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.
    Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N
    AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance.
    Murphy DJ; Lim D; Armstrong R; McCoy CF; Bashi YHD; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
    Drug Deliv Transl Res; 2023 Aug; 13(8):2072-2082. PubMed ID: 34674162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal rings for delivery of HIV microbicides.
    Malcolm RK; Fetherston SM; McCoy CF; Boyd P; Major I
    Int J Womens Health; 2012; 4():595-605. PubMed ID: 23204872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
    Sivin I; Mishell DR; Victor A; Diaz S; Alvarez-Sanchez F; Nielsen NC; Akinla O; Pyorala T; Coutinho E; Faundes A; Roy S; Brenner PF; Ahren T; Pavez M; Brache V; Giwa-Osagie OF; Fasan MO; Zausner-Guelman B; Darze E; Gama daSilva JC; Diaz J; Jackanicz TM; Stern J; Nash HA
    Contraception; 1981 Oct; 24(4):377-92. PubMed ID: 6797783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.
    Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK
    Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.